Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial

BACKGROUND: Acute exacerbation (AE) in idiopathic pulmonary fibrosis and other idiopathic interstitial pneumonias (IIPs) are poor prognostic events although they are usually treated with conventional therapy with corticosteroids and immunosuppressants. Previously, we demonstrated the safety and effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arai, Toru, Kida, Hiroshi, Ogata, Yoshitaka, Marumo, Satoshi, Matsuoka, Hiroto, Gohma, Iwao, Yamamoto, Suguru, Mori, Masahide, Sugimoto, Chikatoshi, Tachibana, Kazunobu, Akira, Masanori, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Interstitial Lung Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239513/
https://www.ncbi.nlm.nih.gov/pubmed/32423894
http://dx.doi.org/10.1136/bmjresp-2020-000558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239513/
https://www.ncbi.nlm.nih.gov/pubmed/32423894
http://dx.doi.org/10.1136/bmjresp-2020-000558

Ejemplares similares